Cite
HARVARD Citation
Dimopoulos, M. et al. (2021). Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial. Lancet oncology. 22 (6), pp. 801-812. [Online].